Advancing ICU mortality prediction in community-acquired pneumonia: Combining fibrinogen-to-albumin ratio, CT severity score, PSI, and CURB-65
Biomolecules and Biomedicine · 26.02.2025 · 25 (9) · 2083-2091
DOI: 10.17305/bb.2025.12127 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomolecules and Biomedicine, online erschienen am 26.02.2025. Verfasst von Ece Unal Cetin und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Faculty of Medicine, Çanakkale Onsekiz Mart University, Çanakkale, Turkey. Hauptthemen laut MEDLINE: Community-Acquired Infections, Fibrinogen, Pneumonia, Serum Albumin. Die Arbeit wurde bisher 10-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Community-acquired pneumonia (CAP) is a leading cause of ICU admissions, with significant morbidity and mortality. Traditional risk stratification tools, such as CURB-65, the pneumonia severity index (PSI), and computed tomography severity scores (CT-SS) are widely used for prognosis but could be improved by incorporating novel biomarkers. This retrospective study evaluated the fibrinogen-to-albumin ratio (FAR) as an additional predictor of 30-day mortality in ICU patients with CAP. A total of 158 CAP patients admitted to a tertiary care ICU were included. Baseline data encompassed demographic, clinical, laboratory, and radiological parameters, including FAR, CURB-65, PSI, and CT-SS. Logistic regression and receiver operating characteristic curve (ROC) analyses were conducted to assess mortality predictors. The 30-day mortality rate was 70.88% (112/158). Higher FAR, PSI, CURB-65, CT-SS, and lactate levels were independently associated with increased mortality (P < 0.05). FAR demonstrated strong discriminatory power (area under the receiver operating characteristic [AUROC]: 0.704) and significantly improved the predictive accuracy of established models. Adding FAR to PSI increased the AUROC from 0.705 to 0.791 (P = 0.009), while combining FAR, CT-SS, and PSI yielded the highest predictive accuracy (AUROC: 0.844, P = 0.032). These findings suggest that FAR, which reflects both inflammation and nutritional status, complements traditional risk assessment tools by providing a dynamic perspective. Integrating FAR into existing models enhances the identification of high-risk patients, enabling timely interventions and more efficient resource allocation in the ICU.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Internal Medicine, Faculty of Medicine, Çanakkale Onsekiz Mart University, Çanakkale, Turkey.
- Department of Emergency Medicine, Faculty of Medicine, Çanakkale Onsekiz Mart University School of Medicine, Çanakkale, Turkey.
- Department of Anesthesiology and Reanimation, Faculty of Medicine, Çanakkale Onsekiz Mart University School of Medicine, Çanakkale, Turkey.
- Department of Internal Medicine, Çanakkale State Hospital, Çanakkale, Turkey.
- Department of Gastroenterology, Faculty of Medicine, Çanakkale Onsekiz Mart University, Çanakkale, Turkey.
Zitieren
APA
Unal Cetin, E., Kurtkulagi, O., Kamis, F., Das, M., Simsek, E., Cetin, A. U., & Beyazit, Y. (2025). Advancing ICU mortality prediction in community-acquired pneumonia: Combining fibrinogen-to-albumin ratio, CT severity score, PSI, and CURB-65. Biomolecules and Biomedicine, 25(9), 2083-2091. https://doi.org/10.17305/bb.2025.12127
Vancouver
Unal Cetin E, Kurtkulagi O, Kamis F, Das M, Simsek E, Cetin AU, et al. Advancing ICU mortality prediction in community-acquired pneumonia: Combining fibrinogen-to-albumin ratio, CT severity score, PSI, and CURB-65. Biomolecules and Biomedicine. 2025;25(9):2083-2091. doi:10.17305/bb.2025.12127
BibTeX
@article{UnalCetin2025,
author = {Unal Cetin, Ece and Kurtkulagi, Ozge and Kamis, Fatih and Das, Murat and Simsek, Esen and Cetin, Adil Ugur and Beyazit, Yavuz},
title = {Advancing ICU mortality prediction in community-acquired pneumonia: Combining fibrinogen-to-albumin ratio, CT severity score, PSI, and CURB-65},
journal = {Biomolecules and Biomedicine},
year = {2025},
volume = {25},
number = {9},
pages = {2083--2091},
doi = {10.17305/bb.2025.12127}
}
EUVIMED